Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.

Vitamin D may help prevent or reduce hair loss after COVID-19.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Particulate matter causes inflammation in hair cells, potentially harming hair growth.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

sPLA2-X is crucial for normal hair growth and follicle health.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Microneedling is a simple, affordable treatment that helps with scars, wrinkles, stretch marks, and hair growth by boosting collagen.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Understanding and targeting specific molecules can help reduce scarring and promote scar-free healing.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

Scarless healing is complex and influenced by genetics and environment, while better understanding could improve scar treatment.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

CD44 variant changes start alopecia areata, but don't maintain it.

Standardizing PRP preparation and application could improve its effectiveness for chronic pain relief.

Vitiligo and alopecia areata may have similar causes despite their differences.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.